Sabaldan, Rowena .
HRN: 01-15-48 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/29/2022
AMPICILLIN 1GM (VIAL)
12/29/2022
01/04/2023
IV
2g
Q6
PROM
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes